These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1699855)

  • 1. Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatment of advanced cervical cancer.
    Angiola G; Bloss JD; DiSaia PJ; Warner AS; Manetta A; Berman ML
    Gynecol Oncol; 1990 Nov; 39(2):214-7. PubMed ID: 1699855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
    Thurnher D; Kletzmayr J; Formanek M; Quint C; Czerny C; Burian M; Kornek G
    Oncology; 2001; 61(2):143-6. PubMed ID: 11528253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature.
    Gardner G; Mesler D; Gitelman HJ
    Ren Fail; 1989; 11(2-3):133-7. PubMed ID: 2482985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.
    Jackson AM; Rose BD; Graff LG; Jacobs JB; Schwartz JH; Strauss GM; Yang JP; Rudnick MR; Elfenbein IB; Narins RG
    Ann Intern Med; 1984 Jul; 101(1):41-4. PubMed ID: 6203452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial with neoadjuvant chemotherapy.
    Sardi JE
    Gynecol Oncol; 1996 Aug; 62(2):321-2. PubMed ID: 8751571
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy in advanced carcinoma of the cervix AOFOG Cervical Cancer Study Group report on Manila meeting July 1983.
    Asia Oceania J Obstet Gynaecol; 1984 Dec; 10(4):429-33. PubMed ID: 6085254
    [No Abstract]   [Full Text] [Related]  

  • 8. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column.
    Watson PR; Guthrie TH; Caruana RJ
    Cancer; 1989 Oct; 64(7):1400-3. PubMed ID: 2528403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri.
    Sardi J; Sananes C; Giaroli A; Maya G; di Paola G
    Gynecol Oncol; 1990 Sep; 38(3):486-93. PubMed ID: 1699851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemotherapy in locally advanced squamous carcinoma of the uterine cervix (IB2 - IIIB stage)].
    Kornovski Ia; Ianeva R; Gorchev G; Tsekov Kh; Uzunov S; Filev S
    Akush Ginekol (Sofiia); 2002; 41(4):39-44. PubMed ID: 12516261
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy--a case report and review of the literature.
    van der Heijden M; Ackland SP; Deveridge S
    Acta Oncol; 1998; 37(1):107-9. PubMed ID: 9572663
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
    Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
    Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjunctive chemotherapy after radical hysterectomy for cervical carcinoma--preliminary report].
    Lai CH; Lin TS; Chen HF
    Changgeng Yi Xue Za Zhi; 1987 Dec; 10(4):307-13. PubMed ID: 2458174
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine).
    Soeters R; Bloch B; Levin W; Dehaeck CM; Goldberg G
    Gynecol Oncol; 1989 Apr; 33(1):44-5. PubMed ID: 2467844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible new trend in the management of the carcinoma of the cervix uteri.
    Sardi JE; di Paola GR; Cachau A; Ortiz OC; Sananes C; Giaroli A; Martins D; Peluffo M
    Gynecol Oncol; 1986 Oct; 25(2):139-49. PubMed ID: 2428700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report.
    Gradishar WJ; Vokes EE; Ni K; Panje WR
    Cancer; 1990 Nov; 66(9):1914-8. PubMed ID: 2224786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in radically operated cervix cancer].
    Lahousen M; Haas J
    Gynakol Rundsch; 1991; 31 Suppl 2():237-8. PubMed ID: 1724226
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson syndrome, respiratory distress and acute renal failure due to synergic bleomycin-cisplatin toxicity.
    Brodsky A; Aparici I; Argeri C; Goldenberg D
    J Clin Pharmacol; 1989 Sep; 29(9):821-3. PubMed ID: 2478592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.